Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 11 , ISSUE 4 ( July-August, 2019 ) > List of Articles

RESEARCH ARTICLE

Evaluation of Risk of Malignancy Index 5—A New Indicator in Differentiating Benign and Malignant Ovarian Masses

Nirmala C Shekar, Pandu Dasappa, Nagendra P Nagothi

Keywords : CA125, Menopausal status, Risk of malignancy index, Ultrasound score

Citation Information : Shekar NC, Dasappa P, Nagothi NP. Evaluation of Risk of Malignancy Index 5—A New Indicator in Differentiating Benign and Malignant Ovarian Masses. J South Asian Feder Obs Gynae 2019; 11 (4):258-262.

DOI: 10.5005/jp-journals-10006-1706

License: CC BY-NC 4.0

Published Online: 01-12-2018

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

Objective: To evaluate the effectiveness of the risk of malignancy index 5 (RMI5)—a new indicator in differentiating benign and malignant ovarian masses. To compare RMI5 with RMI1, RMI2, RMI3, RMI4, and the individual parameters (CA125, ultrasound score, and menopausal status). Materials and methods: It is a 5-year retrospective record analysis of women admitted with ovarian masses. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), diagnostic accuracy of RMI1, RMI2, RMI3, RMI4, RMI5, and CA125, ultrasound score, and menopausal status were calculated. Results: Risk of malignancy index 5 is a better indicator of malignancy compared to the other indices. This study confirms that the five RMI indices were more accurate than menopausal status, CA125 level, and ultrasound score separately. RMI2 and RMI5 had p = 0.047 and 0.034, respectively, and hence were more accurate as compared to other indices by univariate analysis. Risk of malignancy index 5 had sensitivity and specificity of 61.5% and 93.17%, respectively, at a cutoff of 25. CA125 has better sensitivity of 80% in detecting malignant ovarian tumors than other individual parameters. Conclusion: Risk of malignancy index 5 better discriminates malignant from benign ovarian masses as compared to other malignancy indices.


HTML PDF Share
  1. Goldstein SR. Postmenopausal adnexal cysts: how clinical management has evolved. Am J Obstet Gynecol 1996;175(6): 1498–1501. DOI: 10.1016/S0002-9378(96)70097-2.
  2. Vernooij F, Heintz AP, Coebergh JW, et al. Specialized and high volume care leads to better outcomes of ovarian cancer treatment in the Netherlands. Gynecol Oncol 2009;112(3):455–461. DOI: 10.1016/j.ygyno.2008.11.011.
  3. Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990;97(10):922–929. DOI: 10.1111/j.1471-0528.1990.tb02448.x.
  4. Tingulstad S, Hagen B, Skjeldestad FE, et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings, and menopausal status in the pre-operative diagnosis of adnexal masses. Br J Obstet Gynaecol 1996;103(8):826–831. DOI: 10.1111/j.1471-0528.1996.tb09882.x.
  5. Tingulstad S, Hagen B, Skjeldestad FE, et al. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol 1999;93(3):448–452. DOI: 10.1097/00006250-199903000-00028.
  6. Yamamoto Y, Yamada R, Oguri H, et al. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses. Eur J Obstet Gynecol Reprod Biol 2009;144(2):163–167. DOI: 10.1016/j.ejogrb.2009.02.048.
  7. Torres JC, Derchain SF, Faundes A, et al. Risk of malignancy index in preoperative evaluation of clinically restricted ovarian cancer. Sao Paulo Med J 2002;120(3):72–76. DOI: 10.1590/S1516-31802002000300003.
  8. FIGO Cancer Committee. Staging announcement. Gynecol Oncol 1986;25:383–385. DOI: 10.1016/0090-8258(86)90092-2.
  9. Ulusoy S, Akbayir O, Numanoglu C, et al. The risk of malignancy index in discrimination of adnexal masses. Int J Gynecol Obstet 2007;96(3):186–191. DOI: 10.1016/j.ijgo.2006.10.006.
  10. Kroon E, Andolf E. Diagnosis and follow up of simple ovarian cysts detected by ultrasound in postmenopausal women. Obstet Gynecol 1995;85(2):211–214. DOI: 10.1016/0029-7844(94)00366-L.
  11. Leelahakorn S, Tangjitgamol S, Manusirivithaya S, et al. Comparison of ultrasound score, CA125, menopausal status, and risk of malignancy index in differentiating between benign and borderline or malignant ovarian tumors. J Med Assoc Thai 2005;88(Suppl 2): S22–S30.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.